Jellatech
Jellatech is a technology company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Jellatech.
Jellatech is a technology company.
Key people at Jellatech.
Key people at Jellatech.
Jellatech is a B2B biotech startup specializing in cellular agriculture to produce high-quality, bio-identical, animal-free collagen and gelatin from animal cells, targeting industries like healthcare, food and beverages, cosmetics, and pharmaceuticals.[1][2][3][5] Founded in 2020 and based in Raleigh, North Carolina, it serves manufacturers seeking sustainable alternatives to traditional animal-sourced ingredients, solving ethical, environmental, and supply chain inefficiencies in a $3.5 billion market growing at 9% CAGR by eliminating animal dependency, reducing disease risks, and enabling scalable, vegan production.[3][4][5] The company has raised over $5.5 million, including a $3.5 million oversubscribed seed round, and recently expanded with a new GLP-certified facility for pre-clinical trials and R&D in human collagen for biomedical applications, signaling strong growth momentum.[4][6]
Jellatech was founded in 2020 by Stephanie Michelsen (CEO) and Kylie van Deinsen-Hesp in Raleigh, NC, emerging from a vision to disrupt the animal-dependent collagen and gelatin supply chain amid rising ethical and sustainability concerns.[2][4][5] Michelsen, leveraging expertise in biotech innovation, identified inefficiencies like animal slaughter, shipping, and disease risks in traditional production from livestock bones and skin.[2][3] The idea gained traction through cellular agriculture—cultivating collagen directly from animal cells in bioreactors—backed early by investors like Big Idea Ventures, Sustainable Food Ventures, byFounders, and CULT Food Sciences ($2M in 2021).[2][3][4] Pivotal moments include its November launch as the first cell-based collagen/gelatin company and a 2022 brand update focusing on human-identical proteins for healthcare.[2][4]
Jellatech rides the cellular agriculture wave, addressing global demands for sustainable proteins amid climate pressures and animal welfare scrutiny in a collagen market strained by meat byproducts.[1][5] Timing aligns with rising consumer preference for ethical ingredients and regulatory pushes for alternatives, amplified by post-2020 biotech funding surges.[2][4] Favorable forces include biotech advances in bioreactors and synthetic biology, enabling cost-effective scaling, plus cross-industry needs—from food's clean-label trends to healthcare's regenerative medicine boom.[1][6] It influences the ecosystem by pioneering animal-cell tech, fostering R&D hubs, and setting standards for animal-free ingredients, potentially accelerating adoption in a sector pivotal to net-zero food systems.[1][4][5]
Jellatech is poised for biomedical dominance with its GLP facility enabling 2026 trials and partnerships in longevity/healthcare, while expanding food/cosmetics via seed funding momentum.[4][6] Trends like precision fermentation maturation, vegan biomaterial demand, and GLP-compliant scaling will propel growth, potentially capturing shares of the $3.5B+ market.[3][6] Its influence may evolve from niche disruptor to ecosystem leader, collaborating on "next-gen" regenerative solutions and redefining sustainable biotech—cementing its trailblazing role in animal-free innovation.[1][4]
